Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

North Carolina was among 15 states to reach the $7.4 billion settlement in January with Purdue Pharma and its owners, the ...

It’s part of the settlement with the billionaire Sackler family of Massachusetts ... management doctor reached for Purdue Pharma’s OxyContin. “They were giving them out like Tic Tacs ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...

That's the company that makes OxyContin. The tentative deal is worth more than $7 billion. It includes the company's owners, members of the Sackler family. However, it does not give them immunity ...

Surprisingly, publicists for the Sackler family—the owners of Purdue, which manufactures OxyContin, and, as the purported architects of the "opioid epidemic," the epitome of contemporary capitalist ...

Purdue Pharma and its controlling Sackler family have offered a new settlement ... centred around the promotion and marketing of its OxyContin (oxycodone) brand, in a prepared statement.

Purdue, its owners, and several state attorneys general announced the broad strokes of a deal last month that would resolve thousands of lawsuits alleging that its OxyContin pain medication caused ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...